Cite
HARVARD Citation
Chau, I. et al. (n.d.). 1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types. Annals of oncology. p. . [Online].